In an effort to increase treatment benefits, combinations of targeted therapies are currently being explored.
Such map reveals the most benefiting combination of storage means for both reactants.
Silicon nitride and SiAlON ceramics are promising engineering and structural ceramics due to their benefit combination of mechanical, thermal, and chemical properties.
Previous in vitro studies investigating the benefits of combination therapy for the treatment of XDR AB suggest that effective combinations may be strain- or clone-specific [ 8- 10].
The benefits of combination therapy in lithium nonresponders are therefore unknown from this study, although other studies (Hardoy et al. [2005]; Yatham et al. [2004]) have suggested that lithium nonresponders may benefit from combination therapy with quetiapine and lithium.
Atomic-thick nano-carbon materials might satisfy the scaling issue and give great benefits with combination of electrical/mechanical/optical advantages.
The benefits of combination therapy were unaffected by delay.
There are several potential benefits with combination therapy.
The benefits from combination therapy may be more pronounced in patients with good performance status.
Recent randomized clinical trials (RCTs) have demonstrated survival benefits for combination therapy compared to gemcitabine alone.
